The changes come as the wider retail-pharmacy market has been upended in recent years.
drugstores
Hims & Hers launch of compounded $49 Wegovy pill pummels Novo Nordisk’s shares
Published: Feb. 5, 2026 at 10:56 a.m. ET Hims & Hers Health launched a cheaper, compounded version…
CVS’s stock rallies as health giant signals stronger-than-expected results in 2025
CVS Health’s stock was up about 4% at the market open on Tuesday after the company…
Novo Nordisk’s Wegovy could soon have a new sales outlet in the U.S.
Telehealth company Hims & Hers says it is in “active discussions” with Novo Nordisk about selling…
Hims & Hers stock nears one-year low amid battle over compounded Wegovy pill
Published: Feb. 6, 2026 at 3:29 p.m. ET Hims & Hers Health’s stock was on track to…